EI
BIOA

EAM Investors’s BioAge Labs BIOA Stock Holding History

EAM Investors’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$609K Buy
+34,809
New +$670K 0.07% 250

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

EAM Investors's BIOA Position: Q1 2026 in Review

EAM Investors opened a new position in BioAge Labs (BIOA) in Q1 2026: 34,809 shares worth $609K. The stake represents 0.07% of the portfolio and ranks #250 among its holdings.

144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • EAM Investors held 34,809 shares of BioAge Labs worth $609K as of Q1 2026.
  • BioAge Labs was a new EAM Investors position in Q1 2026.
  • BioAge Labs made up 0.07% of EAM Investors's portfolio in Q1 2026, its #250 holding.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on EAM Investors's 13F filing for Q1 2026, filed 13 May 2026.